Skip to content Skip to sidebar Skip to footer

Featured Post

Likelihood of Confusion: Is 15% The Magic Number?

David Bernstein, Partner at Debevoise & Plimpton, gave an interesting presentation yesterday at NYU Law Engelberg …

Read more Likelihood of Confusion: Is 15% The Magic Number?

Latest posts

How do we encourage innovation on “long COVID”?

How do we encourage innovation on “long COVID”?

By Jacob S. Sherkow , Lisa Larrimore Ouellette , Nicholson Price , and Rachel Sachs Since the pande… Read more How do we encourage innovation on “long COVID”?
Motorola v. Hytera: Why Might Government Bring a Criminal Trade Secrets Case After a Successful Civil One?

Motorola v. Hytera: Why Might Government Bring a Criminal Trade Secrets Case After a Successful Civil One?

A federal indictment was unsealed yesterday in the Northern District of Illinois, charging Hytera, … Read more Motorola v. Hytera: Why Might Government Bring a Criminal Trade Secrets Case After a Successful Civil One?
What are the challenges in developing information around mixing-and-matching COVID-19 vaccines and therapies?

What are the challenges in developing information around mixing-and-matching COVID-19 vaccines and therapies?

By Rachel Sachs , Jacob S. Sherkow , Lisa Larrimore Ouellette , and Nicholson Price The FDA has now… Read more What are the challenges in developing information around mixing-and-matching COVID-19 vaccines and therapies?
Jessica Litman: Who Cares What Edward Rogers Thought About Trademark Law?

Jessica Litman: Who Cares What Edward Rogers Thought About Trademark Law?

Professor Jessica Litman has a fascinating forthcoming book chapter on the history of the Lanham Ac… Read more Jessica Litman: Who Cares What Edward Rogers Thought About Trademark Law?
How does pregnancy factor into COVID-19 innovation?

How does pregnancy factor into COVID-19 innovation?

By Nicholson Price , Rachel Sachs , Jacob S. Sherkow , and Lisa Larrimore Ouellette Pregnant people… Read more How does pregnancy factor into COVID-19 innovation?
Molnupiravir may become the first COVID-19 pill. What took so long?

Molnupiravir may become the first COVID-19 pill. What took so long?

By Lisa Larrimore Ouellette , Nicholson Price , Rachel Sachs , and Jacob S. Sherkow On October 1, t… Read more Molnupiravir may become the first COVID-19 pill. What took so long?